S&P 500   3,934.38
DOW   33,476.46
QQQ   282.04
Retirement Doesn't Have to Mean Golf Courses and Fishing — It Can Be Whatever You Want It to Be.
Defy EOY Volatility with Artificial Intelligence (Ad)pixel
Costco vs Amazon: an end of the year showdown
There Is Fundamental Value In Broadcom, And It Yields 3.35% 
Defy EOY Volatility with Artificial Intelligence (Ad)pixel
Closing prices for crude oil, gold and other commodities
Discount Retailers Could Make Good Bargain Stocks
Defy EOY Volatility with Artificial Intelligence (Ad)pixel
How major US stock indexes fared Friday 12/9/2022
K-pop star among 8 to join Japan tycoon Maezawa's moon trip
S&P 500   3,934.38
DOW   33,476.46
QQQ   282.04
Retirement Doesn't Have to Mean Golf Courses and Fishing — It Can Be Whatever You Want It to Be.
Defy EOY Volatility with Artificial Intelligence (Ad)pixel
Costco vs Amazon: an end of the year showdown
There Is Fundamental Value In Broadcom, And It Yields 3.35% 
Defy EOY Volatility with Artificial Intelligence (Ad)pixel
Closing prices for crude oil, gold and other commodities
Discount Retailers Could Make Good Bargain Stocks
Defy EOY Volatility with Artificial Intelligence (Ad)pixel
How major US stock indexes fared Friday 12/9/2022
K-pop star among 8 to join Japan tycoon Maezawa's moon trip
S&P 500   3,934.38
DOW   33,476.46
QQQ   282.04
Retirement Doesn't Have to Mean Golf Courses and Fishing — It Can Be Whatever You Want It to Be.
Defy EOY Volatility with Artificial Intelligence (Ad)pixel
Costco vs Amazon: an end of the year showdown
There Is Fundamental Value In Broadcom, And It Yields 3.35% 
Defy EOY Volatility with Artificial Intelligence (Ad)pixel
Closing prices for crude oil, gold and other commodities
Discount Retailers Could Make Good Bargain Stocks
Defy EOY Volatility with Artificial Intelligence (Ad)pixel
How major US stock indexes fared Friday 12/9/2022
K-pop star among 8 to join Japan tycoon Maezawa's moon trip
S&P 500   3,934.38
DOW   33,476.46
QQQ   282.04
Retirement Doesn't Have to Mean Golf Courses and Fishing — It Can Be Whatever You Want It to Be.
Defy EOY Volatility with Artificial Intelligence (Ad)pixel
Costco vs Amazon: an end of the year showdown
There Is Fundamental Value In Broadcom, And It Yields 3.35% 
Defy EOY Volatility with Artificial Intelligence (Ad)pixel
Closing prices for crude oil, gold and other commodities
Discount Retailers Could Make Good Bargain Stocks
Defy EOY Volatility with Artificial Intelligence (Ad)pixel
How major US stock indexes fared Friday 12/9/2022
K-pop star among 8 to join Japan tycoon Maezawa's moon trip

Bionano Genomics - BNGO Stock Forecast, Price & News

$2.12
-0.04 (-1.85%)
(As of 12/9/2022 12:00 AM ET)
Add
Compare
Today's Range
$2.11
$2.20
50-Day Range
$1.80
$2.81
52-Week Range
$1.16
$4.35
Volume
5.89 million shs
Average Volume
7.55 million shs
Market Capitalization
$629.48 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.50

Bionano Genomics MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
348.1% Upside
$9.50 Price Target
Short Interest
Healthy
14.39% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-1.75mentions of Bionano Genomics in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.58 out of 5 stars

Medical Sector

914th out of 1,034 stocks

Analytical Instruments Industry

25th out of 29 stocks

BNGO stock logo

About Bionano Genomics (NASDAQ:BNGO) Stock

Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight. The company also provides Saphyr and Bionano compute servers; and NxClinical which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; EpiPanelDx PLUS, a genetic testing panel for patients who have experienced seizures, infantile spasms, encephalopathy, or febrile seizures; PGx test, which identifies over 60 alleles in 11 genes. The company was founded in 2003 and is headquartered in San Diego, California.

Receive BNGO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bionano Genomics and its competitors with MarketBeat's FREE daily newsletter.

BNGO Stock News Headlines

Bionano Genomics (NASDAQ:BNGO) Trading Down 5%
Why Bionano Genomics' Shares Spiked 16.42% on Tuesday
See More Headlines
Receive BNGO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bionano Genomics and its competitors with MarketBeat's FREE daily newsletter.

BNGO Company Calendar

Last Earnings
11/03/2022
Today
12/09/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
3/07/2023

Industry, Sector and Symbol

Industry
Analytical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:BNGO
Fax
N/A
Employees
299
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$9.50
High Stock Price Forecast
$12.00
Low Stock Price Forecast
$7.00
Forecasted Upside/Downside
+348.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-72,430,000.00
Net Margins
-451.42%
Pretax Margin
-473.39%

Debt

Sales & Book Value

Annual Sales
$17.98 million
Book Value
$1.17 per share

Miscellaneous

Free Float
293,361,000
Market Cap
$629.48 million
Optionable
Not Optionable
Beta
2.15

Key Executives

  • Dr. Robert Erik Holmlin M.B.A. (Age 54)
    Ph.D., Pres, CEO, Sec. & Director
    Comp: $660.84k
  • Mr. Mark Oldakowski (Age 48)
    Chief Operating Officer
    Comp: $487.73k
  • Mr. Christopher P. Stewart (Age 52)
    Chief Financial Officer
  • Mr. Mark Adamchak CPA
    VP of Accounting & Controller
  • Jonathan Dixon
    Global Head of Legal
  • Mr. Stanislas Marin M.B.A.
    M.S., Head of Global Sales
  • Ms. Helene Klein
    Chief People Officer
  • Dr. Alka Chaubey FACMG (Age 49)
    Ph.D., Chief Medical Officer
  • Dr. Soheil Shams Ph.D. (Age 58)
    CIO of Emeritus
  • Ms. Donna Polizio
    Global Head of Market Access













BNGO Stock - Frequently Asked Questions

Should I buy or sell Bionano Genomics stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bionano Genomics in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" BNGO shares.
View BNGO analyst ratings
or view top-rated stocks.

What is Bionano Genomics' stock price forecast for 2023?

2 analysts have issued 12-month price objectives for Bionano Genomics' stock. Their BNGO share price forecasts range from $7.00 to $12.00. On average, they predict the company's share price to reach $9.50 in the next twelve months. This suggests a possible upside of 348.1% from the stock's current price.
View analysts price targets for BNGO
or view top-rated stocks among Wall Street analysts.

How have BNGO shares performed in 2022?

Bionano Genomics' stock was trading at $2.99 at the beginning of 2022. Since then, BNGO shares have decreased by 29.1% and is now trading at $2.12.
View the best growth stocks for 2022 here
.

When is Bionano Genomics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 7th 2023.
View our BNGO earnings forecast
.

How were Bionano Genomics' earnings last quarter?

Bionano Genomics, Inc. (NASDAQ:BNGO) issued its quarterly earnings results on Thursday, November, 3rd. The company reported ($0.11) EPS for the quarter, beating the consensus estimate of ($0.12) by $0.01. The firm earned $7.22 million during the quarter, compared to analyst estimates of $6.70 million. Bionano Genomics had a negative trailing twelve-month return on equity of 38.48% and a negative net margin of 451.42%.

What guidance has Bionano Genomics issued on next quarter's earnings?

Bionano Genomics updated its FY 2022 earnings guidance on Friday, November, 18th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $27.10 million-$27.60 million, compared to the consensus revenue estimate of $26.41 million.

What is R. Erik Holmlin's approval rating as Bionano Genomics' CEO?

17 employees have rated Bionano Genomics Chief Executive Officer R. Erik Holmlin on Glassdoor.com. R. Erik Holmlin has an approval rating of 73% among the company's employees. 71.0% of employees surveyed would recommend working at Bionano Genomics to a friend.

What other stocks do shareholders of Bionano Genomics own?
When did Bionano Genomics IPO?

(BNGO) raised $16 million in an initial public offering (IPO) on the week of August 20th 2018. The company issued 2,500,000 shares at $6.00-$7.00 per share. Roth Capital Partners and Maxim Group served as the underwriters for the IPO and LifeSci Capital was co-manager.

What is Bionano Genomics' stock symbol?

Bionano Genomics trades on the NASDAQ under the ticker symbol "BNGO."

Who are Bionano Genomics' major shareholders?

Bionano Genomics' stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (7.28%), Vanguard Group Inc. (5.30%), State Street Corp (3.19%), Mitsubishi UFJ Kokusai Asset Management Co. Ltd. (0.52%), Renaissance Technologies LLC (0.47%) and Bank of New York Mellon Corp (0.45%). Insiders that own company stock include R Erik Holmlin and Yvonne Linney.
View institutional ownership trends
.

How do I buy shares of Bionano Genomics?

Shares of BNGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Bionano Genomics' stock price today?

One share of BNGO stock can currently be purchased for approximately $2.12.

How much money does Bionano Genomics make?

Bionano Genomics (NASDAQ:BNGO) has a market capitalization of $629.48 million and generates $17.98 million in revenue each year. The company earns $-72,430,000.00 in net income (profit) each year or ($0.41) on an earnings per share basis.

How many employees does Bionano Genomics have?

The company employs 299 workers across the globe.

How can I contact Bionano Genomics?

Bionano Genomics' mailing address is 9540 TOWNE CENTRE DRIVE SUITE 100, SAN DIEGO CA, 92121. The official website for the company is www.bionanogenomics.com. The company can be reached via phone at (858) 888-7600 or via email at arr@lifesciadvisors.com.

This page (NASDAQ:BNGO) was last updated on 12/10/2022 by MarketBeat.com Staff